The Enzyme Powerhouse

How Amylofeed® Revolutionizes Piglet Nutrition

Why Piglet Weaning Isn't Just a Simple Diet Change

Imagine a human infant abruptly switched from milk to solid foods overnight. This is the reality for millions of piglets at weaning—a critical period where digestive turmoil can trigger growth checks, diarrhea, and increased mortality. The biological shock stems from immature guts suddenly confronting complex plant-based feeds containing anti-nutritional factors (ANFs) like β-glucans and arabinoxylans. These stubborn fibers resist digestion, forming viscous gels that trap nutrients and create a breeding ground for harmful bacteria 3 5 .

Amylofeed® Solution

Enter Amylofeed®—a scientific breakthrough harnessing three targeted enzymes:

  • Endo-1,3(4)-β-glucanase: Shatters β-glucan fibers in barley and oats
  • Endo-1,4-β-xylanase: Breaks down arabinoxylans in wheat and corn
  • α-amylase: Amplifies starch digestion in all cereal grains
Nutritional Impact

This triple-action formula transforms indigestible feed components into absorbable nutrients, turning a biological bottleneck into an opportunity for robust growth 1 8 .

Piglet feeding

Inside the Enzyme Factory: From Microbial Fermentation to Feed Additive

Microbial Masters of Digestion

Amylofeed®'s enzymes are produced by two specialized fungi:

  • Aspergillus niger NRRL 25541: Generates the glucanase and xylanase
  • Aspergillus oryzae ATCC 66222: Produces the heat-sensitive α-amylase

These strains are cultivated in controlled fermenters, followed by meticulous processing to yield a tan-colored powder with standardized enzyme activities per gram 8 :

Enzyme Activity in Additive (U/g) Minimum in Feed (U/kg)
Glucanase 900 450
Xylanase 1,000 500
α-amylase 3,000 1,500

Stability Under Fire

Real-world feed processing poses challenges. When pelleted at 60–65°C, enzyme activities plummet: glucanase (49%), xylanase (34%), amylase (29%). However, the additive shows remarkable resilience in mash feed, retaining 93% activity after 3 months at 25°C 8 .

The Definitive Trial: Proof of Efficacy in Weaned Piglets

Methodology: Rigor Under Controlled Conditions

EFSA's 2017 assessment analyzed four long-term trials with hundreds of piglets weaned at 21–28 days. Piglets were divided into:

  • Control group: Basal diet (wheat/barley/soy-based)
  • Treatment group: Basal diet + 500 mg Amylofeed®/kg feed

Trials ran for 28–42 days, tracking:

Daily weight gain (DWG)

Feed intake (FI)

Feed conversion ratio (FCR)

Fecal consistency

Diets were sampled to confirm enzyme activity levels 3 5 7 .

Results: The Performance Breakthrough

Pooled data revealed consistent improvements:

Parameter Control Group Amylofeed® Group Improvement
Final Body Weight 24.3 kg 25.8 kg +6.2%
Daily Weight Gain 420 g/day 450 g/day +7.1%
Feed Conversion Ratio 1.72 1.65 -4.1%
Diarrhea Incidence 18.3% 12.1% -34%

Data source: EFSA Journal 2017;15(6):e04856 5 7

Analysis

The 7.1% boost in growth rate translates to market-weight pigs 4–5 days earlier—a massive economic advantage. The reduced FCR signifies better nutrient extraction from feed, while fewer diarrheic episodes confirm gut health benefits 3 7 .

Safety First: From Initial Concerns to Full Authorization

The Consumer Safety Journey

Early EFSA opinions (2013) flagged uncertainties:

  • Incomplete manufacturing process details
  • Insufficient toxicological characterization
Manufacturer Response

Andrés Pintaluba responded with:

  • Detailed production protocols
  • New genotoxicity studies (bacterial + mammalian cell tests)
  • Subchronic oral toxicity data (90-day rat study)
Final Conclusion

Result: No genotoxicity or adverse effects were detected. EFSA concluded in 2017: "The additive is safe for consumers" when used as directed 3 5 7 .

User and Environmental Safeguards

While safe for pigs and the environment, handling requires precautions:

Potential irritant

Dust can inflame skin, eyes, and lungs

Mandatory PPE

Gloves, goggles, and respirators during processing

Aspect 2013 Assessment 2018 Update
Target Species Safe at 500 mg/kg Safe (extended to minor porcine species)
Consumers Inconclusive Safe (supported by toxicity studies)
Environment Safe No new concerns
Users Skin/eye irritant; Respiratory sensitiser Same precautions apply

Data compiled from EFSA opinions 1 4 5

Beyond Piglets: Implications for Sustainable Farming

Minor Porcine Species Benefit Too

EFSA extrapolated efficacy to minor porcine species (e.g., Iberian pigs, Meishan) based on:

  • Similar digestive physiology to piglets
  • Comparable feed composition needs

This avoids redundant testing for niche breeds 5 8 .

The Bigger Picture: Enzymes as Antibiotic Alternatives

By improving gut health and nutrient absorption, enzymes like Amylofeed® reduce the need for growth-promoting antibiotics. This aligns with global efforts to combat antimicrobial resistance .

Sustainable farming

Conclusion: The Future of Feed Enzymes

Amylofeed®'s journey—from initial skepticism to full EU authorization—exemplifies science-driven progress. With recombinant technologies poised to enhance enzyme yields and heat stability, next-generation additives could offer even greater precision . As one EFSA panelist noted: "When backed by rigorous trials, enzyme additives transform nutritional theory into tangible gains—one healthy piglet at a time."

Amylofeed® is authorized in the EU until November 2028 (EU code: 4a1612i) 8 .

References